← Back to search

COVENANT THERAPEUTICS LLC

CHARLOTTESVILLE, VA, 22903

Unclaimed
Minority Owned

Subcontracting experience

1 record from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Subcontractor
Department of Defense
DURING THE THREE YEARS OF THIS PROJECT, COVENANT THERAPEUTICS WILL SYNTHESIZE LIBRARIES OF COMPOUNDS TO DEVELOP A STRUCTURE-ACTIVITY RELATIONSHIP FOR PEPTIDE DERIVATIVES OF CT-AP1, A COMPOUND WITH ANTIBIOTIC ACTIVITY. WE WILL USE THIS DATA TO SYNTHESIZE A SECOND GENERATION OF ANALOGS WITH IMPROVED ACTIVITY AND FINALLY SYNTHESIZE LARGE QUANTITIES OF 3 LEAD COMPOUNDS FOR IN VIVO STUDIES.
E2065951
Parent award context
Parent award agency: Department of Defense · Defense Health Agency
Parent award NAICS: 541715
Parent award performance state: MD
Parent award description: COMPOUND ASSESSMENT RESEARCH SUPPORT
View parent award on USAspending
—$186,428Dec 3, 2025— – —

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

COVENANT THERAPEUTICS LLC – Charlottesville, VA | UEI KKJLPNVZZWT2 | FedSub